Axxam Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 5

Axxam General Information

Description

Provider of drug discovery services intended for the life sciences industry. The company offers target assessment, assay development, high-throughput screening, hit qualification, and hit-to-lead generation, designed to support pharmaceutical and biotechnology firms in translating innovative biology into bioactive molecules.

Contact Information

Website
www.axxam.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Openzone Campus, Via Meucci, 3
  • Bresso
  • 20091 Milan
  • Italy
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • Openzone Campus, Via Meucci, 3
  • Bresso
  • 20091 Milan
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axxam Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Axxam‘s full profile, request access.

Request a free trial

Axxam Patents

Axxam Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023031319-A1 2,4-dihydro-3h-1,2,4-triazol-3-one p2x7 antagonists Inactive 03-Sep-2021
EP-4015039-A1 Heterocyclic derivatives as p2x7 receptor antagonists Inactive 18-Dec-2020
WO-2022129365-A1 Heterocyclic derivatives as p2x7 receptor antagonists Inactive 18-Dec-2020
AU-2020316080-A1 Bicyclic cx3cr1 receptor agonists Inactive 23-Jul-2019
CA-3148454-A1 Bicyclic cx3cr1 receptor agonists Pending 23-Jul-2019 C07D409/12
To view Axxam’s complete patent history, request access »

Axxam Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axxam Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Axxam‘s full profile, request access.

Request a free trial

Axxam Investments & Acquisitions (5)

Axxam’s most recent deal was a Early Stage VC with Lario Therapeutics for . The deal was made on 07-Nov-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Lario Therapeutics 07-Nov-2023 Early Stage VC Drug Discovery
Hit Discovery Constance 12-Jan-2022 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Rewind Therapeutics 04-Jan-2018 Early Stage VC Drug Discovery
Acousia Therapeutics 14-Dec-2016 Early Stage VC Drug Discovery
Hit Discovery Constance 01-Jan-2013 Joint Venture Other Pharmaceuticals and Biotechnology
To view Axxam’s complete investments and acquisitions history, request access »

Axxam Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Hit Discovery Constance Konstanz, Germany 2013

Axxam FAQs

  • When was Axxam founded?

    Axxam was founded in 2001.

  • Where is Axxam headquartered?

    Axxam is headquartered in Milan, Italy.

  • What is the size of Axxam?

    Axxam has 200 total employees.

  • What industry is Axxam in?

    Axxam’s primary industry is Drug Discovery.

  • Is Axxam a private or public company?

    Axxam is a Private company.

  • What is Axxam’s current revenue?

    The current revenue for Axxam is .

  • Who are Axxam’s investors?

    Keensight Capital has invested in Axxam.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process